Dexcom (DXCM) Operating Leases (2019 - 2026)

Dexcom (DXCM) has 8 years of Operating Leases data on file, last reported at $69.0 million in Q1 2026.

• Operating Leases for Q1 2026 came in at $69.0 million, up 15.58% year-over-year; the trailing twelve-month figure through Mar 2026 was $69.0 million (up 15.58% YoY), and the FY2025 annual result was $73.4 million, up 12.92% from the prior year.
• Operating Leases fell to $69.0 million in Q1 2026 per DXCM's latest filing, from $73.4 million in the prior quarter.
• Over five years, Operating Leases peaked at $94.6 million in Q4 2022 and troughed at $50.6 million in Q3 2025.
• A 5-year average of $76.1 million and a median of $76.8 million in 2024 frame the typical range for Operating Leases.
• The sharpest annual moves came in 2025 and 2026: Operating Leases fell 28.83% in 2025, then climbed 15.58% in 2026.
• A 5-year view of Operating Leases shows it stood at $94.6 million in 2022, then slipped by 15.33% to $80.1 million in 2023, then fell by 18.85% to $65.0 million in 2024, then gained by 12.92% to $73.4 million in 2025, then retreated by 5.99% to $69.0 million in 2026.
• Business Quant data shows DXCM's Operating Leases at $69.0 million in Q1 2026, $73.4 million in Q4 2025, and $50.6 million in Q3 2025.